Powered by a proprietary ADC platform, Oqory is focused on delivering therapies that improve outcomes for patients with ...

Elon Musk’s “public life risks alienating consumers and employees” at Tesla, remarked Oppenheimer analysts in a Tuesday ...

Oppenheimer initiated coverage of IBM (IBM) with an Outperform rating and $320 price target The firm’s bullish stance is based on the view ...

Recludix Pharma, a leader in the discovery of inhibitors of challenging targets for inflammatory disease, today announced ...

Highlights:,Oppenheimer Holdings Inc. (NYSE:OPY) is approaching its ex-dividend date, which determines eligibility for the ...